SCHEMBL30424722

SCHEMBL30424722

Clc1ccnc2[nH]nc(Br)c12

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LRRK2 Q5S007 2/20 0.41
▸ PRKCI P41743 3/20 0.40
▸ AURKB Q96GD4 2/20 0.40
▸ AXL P30530 2/20 0.40
▸ AURKA O14965 1/20 0.40
▸ DAO P14920 2/20 0.38
▸ CDK2 P24941 2/20 0.36
▸ CDK9 P50750 2/20 0.36
▸ CDK5 Q00535 2/20 0.36
▸ CCNT1 O60563 1/20 0.36
▸ CCNA2 P20248 1/20 0.36
▸ CCNA1 P78396 1/20 0.36
▸ CDK5R1 Q15078 1/20 0.36
▸ PDPK1 O15530 2/20 0.34
▸ CDC7 O00311 1/20 0.34
▸ PLK4 O00444 1/20 0.34
▸ CHEK1 O14757 1/20 0.34
▸ MAPK13 O15264 1/20 0.34
▸ DAPK3 O43293 1/20 0.34
▸ DYRK3 O43781 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15799693 1.00 LRRK2 (0.41) LRRK2PRKCIAURKBAXLAURKA
SCHEMBL25245801 0.80 PRKCI (0.42) PRKCIAXLDAOPDPK1
SCHEMBL24348553 0.77 PRKCI (0.32) PRKCIDAOPDPK1
SCHEMBL2693931 0.77 LRRK2 (0.41) LRRK2PRKCIAURKBAXLAURKA
SCHEMBL28813094 0.77 GAA (0.50) LRRK2PRKCIAURKBAXLAURKA
SCHEMBL29514134 0.77 LRRK2 (0.41) LRRK2PRKCIAURKBAXLAURKA
SCHEMBL30406172 0.77 LRRK2 (0.41) LRRK2PRKCIAURKBAXLAURKA
SCHEMBL1944275 0.77 LRRK2 (0.41) LRRK2PRKCIAURKBAXLAURKA
SCHEMBL2693973 0.73 LRRK2 (0.38) LRRK2PRKCIAURKBAXLAURKA
SCHEMBL2691540 0.73 AURKB (0.41) LRRK2PRKCIAURKBAXLAURKA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4436957-A1 THERAPEUTIC INDAZOLE COMPOUNDS AND METHODS OF USE IN THE TREATMENT OF CANCER Genentech, Inc. (US) 2024-10-02 — — EP disclosed
CN-118302411-A Therapeutic indazole compounds and methods of use thereof for the treatment of cancer 基因泰克公司 2024-07-05 — — CN disclosed
WO-2023097195-A1 THERAPEUTIC INDAZOLE COMPOUNDS AND METHODS OF USE IN THE TREATMENT OF CANCER GENENTECH, INC. (US) 2023-06-01 — — WO disclosed
Send feedback